The medical device developer secured funding from backers including Knight Therapeutics as it went public in Canada through a reverse takeover.

The sterility monitoring technology company has raised $25m in funding from investors including Hepalink, and will use the money to support global expansion.

Celgene provided $30m as part of the deal and secured the right to eventually acquire the biotechnology company, which focuses on cancer and fibrosis.

Water vapour-based medical device developer Aegea Medical has raised $36m from new and existing investors including Covidien/Medtronic.

The financial management software provider has raised $30m in a series A round that followed a $20m seed round secured in November 2014.

The news aggregation app provider raised the cash from investors including entertainment and media company Enlight.

The gene editing technology company has raised $64m to close its first two rounds, co-led by Celgene and GlaxoSmithKline-backed SR One, at $89m.

Mitsui has participated in the TV shopping and e-commerce company's third funding round, which follows a $25m series B round raised in 2011.

Corporates Fosun and Tencent co-led the round for the mobile medical devices maker, taking its overall funding to almost $50m.